
執行合夥人 瑞橡資本控股有限公司

執行合夥人 瑞橡資本控股有限公司

營運總監
普樂藥業有限公司

CSO
海康生命科技有限公司

粵港澳大灣區生物科技聯盟副主席

于本熙先生,香港01有限公司董事、前海香港商会执行会长,於2021年榮獲第二屆粵港澳大灣區傑出青年企業家稱號。

九龍金域扶輪社,前主席

Graduated from Renmin University of China, partner of Ausvic Capital, Honorary President of New Territories West Residents Association, Executive Vice President of Hong Kong Hunan Youth Association, member of the 28th and 29th Board of Directors of the Hong Kong Association of Youth. Mainly responsible for investment and collaboration in the fields of blockchain, quantum technology, space technology, and longevity.

Gordon Cheng is the CEO of Cameron Pace Group China (CPGC), the exclusive joint venture set up with famous film industry leader and scientist James Cameron in China, focusing on film and media technologies, especially on 3D areas. In addition to daily operations, Mr. Cheng is also driving the R&D and strategic developments relating to artificial intelligence, advanced 3D display and other cutting edge visual technologies. Mr. Cheng has been the senior management/employee, Board member and advisor for various global and Chinese listed companies across different industries involving finance (JPMorgan, Credit Suisse and Deutsche Bank), natural resources (China Molybdenum), semiconductor (Vimicro), infrastructure/real estate (LaSalle Fund). Mr. Cheng has been active as the Board member and senior advisor on various global initiatives on climate changes and natural conservation, including African Wildlife Foundation and UNIDO.

Dr. Christine Huang Yuan is the Technology Transfer Director of Hong Kong Quantum AI Lab, Founder and Managing Director of HK Longevity Medical Center and Venture Partner of LongeVC . She is also a Senior Research Associate at the University of Hong Kong. Christine was selected as one of Forbes China 2020 “30 Under 30 (Healthcare and Science)”, and a Fellow of the Royal Society of Medicine (UK). She is also a member of the Advisory Board of Wing Wah Charity Foundation Hong Kong, and a columnist to Forbes China. Christine was elected as a Fellow of Guangzhou Youth Federation in Nov 2022.
Christine graduated from Southern Medical University with Doctor of Medicine, and obtained a Master’s degree from the Li Ka Shing Faculty of Medicine of the University of Hong Kong the Li Ka Shing Faculty of Medicine of the University of Hong Kong and later on trained in the neurology department of Queen Mary Hospital in Hong Kong, where she participated in several large-scale international clinical trials. Dr. Huang is skilled in translational medicine, especially in the fields of AI-driven medicine, age-associated diseases (neurodegenerative diseases, cancer, diabetes, etc.) and longevity medicine.

Dr Russell W. Chan is the Chief Technology Officer at Gense Technologies Ltd., an award-winning startup listed on Forbes Asia 100 To Watch 2022. His company’s self-developed portable biomedical imaging device has won grand awards in various technology and entrepreneurship competitions. After obtaining a PhD in Biomedical Engineering from HKU in 2016, he was a postdoc at Stanford University and NYU Langone Health before starting his own business. He is a Junior Fellow of the International Society of Magnetic Resonance in Medicine, and the lead of the R&D focus group and committee member of the Hong Kong Institute of Engineers Biomedical Division.